Premium
Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation
Author(s) -
Abou Dalle Iman,
Kantarjian Hagop,
Ban Sarah A.,
KanagalShamanna Rashmi,
Routbort Mark,
Patel Keyur P.,
Hu Shimin,
Bhalla Kapil,
GarciaManero Guillermo,
DiNardo Courtney D.
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25610
Subject(s) - biology , frameshift mutation , cancer research , germline mutation , myelodysplastic syndromes , genetics , mutation , population , myeloid , gene , immunology , medicine , bone marrow , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom